cbdMD Inc. announced significant amendments to its corporate bylaws effective May 6, 2025. These include the automatic conversion of each outstanding share of its 8% Series A Cumulative Convertible Preferred Stock into thirteen shares of Common Stock. Additionally, the company implemented a one-for-8 reverse stock split of its issued and outstanding shares of Common Stock. As a result, the CUSIP number for the Common Stock has changed, and trading on the NYSE American began on a reverse stock split-adjusted basis on May 7, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.